0001209191-15-052245.txt : 20150611
0001209191-15-052245.hdr.sgml : 20150611
20150611152640
ACCESSION NUMBER: 0001209191-15-052245
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150609
FILED AS OF DATE: 20150611
DATE AS OF CHANGE: 20150611
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cidara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001610618
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 461537286
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-752-6170
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: K2 THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20140611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Franson Timothy R
CENTRAL INDEX KEY: 0001471650
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36912
FILM NUMBER: 15925859
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-06-09
0
0001610618
Cidara Therapeutics, Inc.
CDTX
0001471650
Franson Timothy R
6310 NANCY RIDGE DRIVE
SUITE 101
SAN DIEGO
CA
92121
1
0
0
0
Stock Option (right to buy)
15.91
2015-06-09
4
A
0
9000
0.00
A
2025-06-08
Common Stock
9000
9000
D
The shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant or (ii) the day prior to the date of the Issuer's 2016 annual meeting of stockholders.
/s/ Marc Wilson, Attorney-in-Fact
2015-06-11